Kavita Garg MD, Presenter: Nothing to Disclose

Stephen Malkoski, Abstract Co-Author: Nothing to Disclose

Detection of subsolid (ground glass and part-solid nodules) nodules is expected to increase if CT screening for lung cancer becomes widespread. However, many questions remain, including whom to screen, how often, and for how long, especially in regards to the subsolid nodules. Overdiagnosis associated with screening is also a concern because we currently do not fully understand the natural history of subsolid nodules. Low-grade adenocarcinomas and adenocarcinoma in situ, typically manifest as subsolid nodules on low-dose CT images and are generally indolent. Integration of nodule features, pathology and patient characteristics (life expectancy, co-morbidities) are important in clinical decision making for management.

Most frequently asked questions about subsolid nodules by clinicians Spectrum of CT findings of subsolid nodules and follow-up algorithm Assessment on follow-up CT and measurement techniques and variability CT and pathology correlations based on 2011 International Lung Adenocarcinoma Classification and implications for 7th edition of the TNM staging Case studies illustrating integrated personalized management decision making ranging from watchful waiting to surgical intervention

http://abstract.rsna.org/uploads/2014/14004944/14004944_6oxw.pdf

Garg, K, Malkoski, S, Subsolid Pulmonary Nodules: What Do the Radiologists and Clinicians Need to Know?.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14004944.html